AIDS
(ISSN: 0269-9370, 1473-5571)
Show only: Full-text on Medscape
2009 - 23 (15)
- Response to correspondence on 'Should Biomarker Estimates of HIV Incidence be Adjusted?'.
- BED estimates of HIV incidence must be adjusted.
- Reply to 'Should biomarker estimates of HIV incidence be adjusted?'.
- BED estimates of HIV incidence must be adjusted.
- Frontostriatal fiber bundle compromise in HIV infection without dementia.
- CCR5 antagonism in HIV infection: ways, effects, and side effects.
- Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents.
- Persistent HIV RNA shedding in semen despite effective antiretroviral therapy.
- Renal function with use of a tenofovir-containing initial antiretroviral regimen.
- Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment.
- AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic.
- HIV-1 Vpr activates the DNA damage response in renal tubule epithelial cells.
- Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl.
- Altered release of regulated upon activation, normal T-cell expressed and secreted protein from human, normal platelets: contribution of distinct HIV-1MN gp41 peptides.
- Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct.
- Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.
- Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.
- The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells.
- Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression.
- Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients.
- Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy.
